当前位置: X-MOL 学术Adv. Funct. Mater. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Dual-Responsive Shape-Transformable Charge-Reversible Nanoparticles Combined with Chemo-Photodynamic-Immunotherapy for the Treatment of Breast Cancer and Lung Metastasis
Advanced Functional Materials ( IF 18.5 ) Pub Date : 2024-07-01 , DOI: 10.1002/adfm.202408581
Wenfeng Jia 1 , Bokai Gong 1 , Jiantao Chen 2 , Jia Yan 1 , Yulong Shi 1 , Hao Wang 3 , Meng Qin 4 , Huile Gao 1
Affiliation  

Herein, a dual-responsive shape-transforming charge-reversal integrated nanomedicine system (DHP@BPP) is developed for the co-delivery of the photosensitizer pyro pheophorbide-α (Ppa), anti-programmed cell death ligand 1 (PD-L1) peptide (dPPA), and tumor-associated macrophages (TAMs)-regulating drug berberrubine (BBR). Hydrophobic Ppa and hydrophilic BBR are linked by matrix metalloproteinase-2 (MMP-2) responsive peptide (PMGMRKLVFF) to form BPP. BPP can self-assemble into spherical nanoparticles with positive charge, which undergo shape transformation to nanofibers upon cleavage by MMP-2 at tumor sites. The dPPA is conjugated with hexa-histidine and polyethylene glycol to form DHP, which is then electrostatically adsorbed onto the surface of BPP to form DHP@BPP with negative surface charge. The DHP not only enhances the tumor-targeting but also induces DHP disassociation and charge reversal of DHP@BPP due to protonation of histidine at the tumor site, thereby increasing tumor penetration while maintaining long blood circulation. Most importantly, through the combination of chemo-photodynamic-immunotherapy, it can repolarize TAMs from M2-type to M1-type while reducing PD-L1 expression to reshape the immunosuppressive tumor microenvironment, thereby synergistically enhancing the effect of immunogenic cell death. In conclusion, this study offered a simple but effective idea for the treatment of immunosuppressive cancers through the combination of shape transformation and charge reversal, integrating chemo-photodynamic-immunotherapy.

中文翻译:


双响应形状可转变电荷可逆纳米粒子联合化疗-光动力-免疫疗法治疗乳腺癌和肺转移



在此,开发了一种双响应形状转换电荷反转集成纳米医学系统(DHP@BPP),用于共同递送光敏剂焦脱镁叶绿酸-α(Ppa)和抗程序性细胞死亡配体1(PD-L1)肽(dPPA)和肿瘤相关巨噬细胞(TAM)调节药物小檗红素(BBR)。疏水性 Ppa 和亲水性 BBR 通过基质金属蛋白酶 2 (MMP-2) 响应肽 (PMGMRKLVFF) 连接形成 BPP。 BPP可以自组装成带正电荷的球形纳米粒子,在肿瘤部位被MMP-2裂解后形状转变为纳米纤维。 dPPA与六组氨酸和聚乙二醇缀合形成DHP,然后静电吸附到BPP表面,形成表面带负电荷的DHP@BPP。 DHP不仅增强了肿瘤靶向性,而且由于组氨酸在肿瘤部位的质子化,诱导DHP解离和DHP@BPP的电荷反转,从而增加肿瘤渗透性,同时维持长时间的血液循环。最重要的是,通过化疗-光动力-免疫疗法的结合,可以将TAM从M2型复极化为M1型,同时减少PD-L1表达,重塑免疫抑制性肿瘤微环境,从而协同增强免疫原性细胞死亡的效果。总之,本研究通过结合形状转变和电荷反转,整合化学-光动力-免疫疗法,为免疫抑制性癌症的治疗提供了一种简单而有效的思路。
更新日期:2024-07-01
down
wechat
bug